SEQUENTSequent Scientific

₹219.1+0.58%

Market Cap

₹5,514.86 Cr

Stock P/E

185.81

ROCE

9.30%

ROE

5.44%

Book Value

₹24.85

Financials

YoY Net Sales

EPS Growth

Operating Margin

Other Updates

2 months ago

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

POSITIVES

•
Strong Q1 FY '26 revenue footing with clear YoY growth.
•
Material EBITDA growth with margin that aligns to mid-teens, signaling operating leverage.

NEGATIVES

•
Seasonality and quarterly variability across geographies could impact short-term growth.
•
Merger-related expenses expected to continue for two quarters due to milestone payments.

Peer comparison data is not available for this stock.